Class Correspondent

Philip Rubin, formerly the CEO and a senior scientist at Haskins Laboratories, has taken a leave from the lab to assume two new responsibilities. He will serve as assistant director for social, behavioral and economic sciences in the executive office of the White House’s Office of Science and Technology Policy, and will be a senior adviser in the National Science Foundation’s Social, Behavioral and Economic Sciences Directorate. Renowned bioethicist Arthur Caplan joined New York University’s Langone Medical Center as director of the new Division of Medical Ethics in the Department of Population Health. Arthur had been at the University of Pennsylvania’s Perelman School of Medicine, where he served as the Sidney D. Caplan Professor of Bioethics. Fred Siegel is now vice provost for student and enrollment services and dean of students at Claremont Graduate University. His duties include the oversight of student recruitment, admissions, registration, retention, student activities, student government, student financing, counseling, minority mentoring, creative services, residential living and student discipline. Formerly, he was an associate vice president at George Washington University. Howard Fingert, M.A.’73, was elected to serve a multiyear term as industry representative to the oncology drugs advisory committee at the U.S. Food and Drug Administration. In this capacity, Howard will represent the regulated biotechnology/pharmaceutical industry for review of new agents to treat cancer and blood diseases. Howard is an oncologist/hematologist and senior medical director at Millennium Pharmaceuticals. He trained at the National Cancer Institute and Harvard, and was an assistant professor at Harvard conducting research in cancer pharmacology. He joined the pharma industry in 1993, focusing on clinical development of anticancer agents for treatment of adult or pediatric malignancies.
Submit a Class Note